Pure Global

Ondansetron versus magnesium infraclavicular brachial plexus block - Trial PACTR201608001747141

Access comprehensive clinical trial information for PACTR201608001747141 through Pure Global AI's free database. This Not Applicable trial is sponsored by Department of anesthesia and surgical ICU ; Tanta University, Faculty of Medicine ; Tanta University, Faculty of Medicine and is currently Completed. The study focuses on Surgery; Other; Orthopaedics; Anaesthesia.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
PACTR201608001747141
Not Applicable
Completed
drug
Trial Details
Pan Africa Clinical Trials Registry โ€ข PACTR201608001747141
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Ondansetron versus magnesium infraclavicular brachial plexus block
Ondansetron versus magnesium sulphate as adjuvants to ultrasound guided infraclavicular brachial plexus block in patients undergoing hand and forearm surgery

Study Focus

drug

Sponsor & Location

Department of anesthesia and surgical ICU ; Tanta University, Faculty of Medicine ; Tanta University, Faculty of Medicine

Tanta University, Faculty of Medicine

Egypt

Timeline & Enrollment

Not Applicable

Jul 01, 2016

Feb 07, 2017

Summary

Brachial plexus block (BPB) is a well-accepted technique to provide anesthesia and analgesia for upper limb orthopedic surgeries. Various adjuvants such as opioids3 , clonidine4, neostigmine, dexamethasone5 , midazolam 6 were added to local anesthetics in brachial plexus block to achieve quick, dense and prolonged block Ondansetron exhibits local anaesthetic properties 10. Ondansetron has demonstrated binding at the opioid m receptors in humans and exhibits agonist activity 11 Magnesium is a physiological calcium channel blocker and noncompetitive antagonist of N-methyl-D-aspartate (NMDA) receptors 14. It has been used with a local anesthetic solution in different regional anesthesia techniques to decrease the onset time of block and to increase the quality and duration of anesthesia The aim of this study is to compare the effects of adding either ondansetron or magnesium sulphate as adjuvants to ultrasound guided infraclavicular brachial plexus block on postoperative analgesia in patients undergoing hand and forearm surgeries.

ICD-10 Classifications

Other surgical procedures
Other medical procedures
During other surgical and medical care
During other surgical and medical care
During other surgical and medical care

Data Source

Pan Africa Clinical Trials Registry

PACTR201608001747141

Non-Device Trial